Abstract
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammatory arthritis in children and many patients have active disease that persists into adulthood. There are differences in the classification and management of JIA in comparison to adult-onset arthritis. Many patients will be taking immunosuppressive medications when they transition to adult care. In addition, they are at risk for comorbid conditions related to bone health, cardiovascular disease, reproductive health, medication toxicity, and complications from their arthritis. Primary care providers have an important role in the care of young adults with JIA. Being knowledgeable about this condition will assist them in anticipating, preventing, and treating late effects of this pediatric-onset condition. This chapter discusses the areas adult providers should consider when caring for young adults with juvenile idiopathic arthritis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
U.S. Department of Education, Office for Civil Rights. Students with disabilities preparing for postsecondary education: know your rights and responsibilities http://www2.ed.gov/about/offices/list/ocr/transition.html. Accessed 13 June 2016.
Centers for Disease Control and Prevention. Adult immunization schedules. http://www.cdc.gov/vaccines/schedules/hcp/adult.html Accessed 7 May 2016.
Cauffman E, Steinberg L. (Im)maturity of judgment in adolescence: why adolescents may be less culpable than adults. Behav Sci Law. 2000;18(6):741–60.
ACP High Value Care JIA. https://www.acponline.org/system/files/documents/clinical_information/high_value_care/clinician_resources/pediatric_adult_care_transitions/rheumatology/jia_transition_tools.pdf. Accessed 7 May 2016.
Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.
Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Cassidy JT, editors. Textbook of pediatric rheumatology. 7th ed. Philadelphia: Elsevier; 2016.
Coulson EJ, Hanson HJM, Foster HE. What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatol Oxf Engl. 2014;53(12):2155–66.
Behrens EM, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343–8.
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet Lond Engl. 2007;369(9563):767–78.
Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K, German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatol Oxf Engl. 2007;46(6):1015–9.
Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, et al. Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2012;10(1):29.
Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56(6):1974–84.
Farragher TM, Lunt M, Plant D, Bunn DK, Barton A, Symmons DPM. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. Arthritis Care Res. 2010;62(5):664–75.
Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatol Oxf Engl. 2002;41(12):1428–35.
Gomez KS, Raza K, Jones SD, Kennedy LG, Calin A. Juvenile onset ankylosing spondylitis—more girls than we thought? J Rheumatol. 1997;24(4):735–7.
Hersh A, von Scheven E, Yelin E. Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol. 2011;7(5):290–5.
Flatø B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol. 2009;36(3):642–50.
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465–82.
Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773–80.
Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(4):1263–71.
Ringold S, Cron RQ. The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic. Pediatr Rheumatol. 2009;7(1):11.
Hospach T, Maier J, Müller-Abt P, Patel A, Horneff G, von Kalle T. Cervical spine involvement in patients with juvenile idiopathic arthritis—MRI follow-up study. Pediatr Rheumatol Online J. 2014;4(12):9.
Bohr A-H, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Müller K. Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J. 2016;14. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704268/ Accessed 10 May 2016.
Coulson EJ, Ng W-F, Goff I, Foster HE. Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology. 2013 Mar 15;ket106.
Feldman DE, Vinet É, Bérard A, Duffy C, Hazel B, Meshefedjian G, et al. Heart disease, hypertension, gestational diabetes and pre-eclampsia/eclampsia in mothers with juvenile arthritis: a nested case-control study. Arthritis Care Res. 2016 (Epub ahead of print) PMID: 27111101.
Anderson JH, Anderson KR, Aulie HA, Crowson CS, Mason TG, Ardoin SP, et al. Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study. Scand J Rheumatol. 2016;8:1–5.
Pelajo CF, Lopez-Benitez JM, Miller LC. Obesity and disease activity in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2012;12(10):3.
Pincus T, Gibson KA, Block JA. Premature mortality: a neglected outcome in rheumatic diseases? Arthritis Care Res. 2015;67(8):1043–6.
Bouayed K, Alyanakian M-A, Cordonnier C, Caillat-Zucman S, Testelin S, Lambrey G, et al. Sjögren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritis. Rheumatology. 2002;41(10):1190–3.
Cassidy JT, Hillman LS. Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis. Rheum Dis Clin N Am. 1997;23(3):499–522.
Zak M, Hassager C, Lovell DJ, Nielsen S, Henderson CJ, Pedersen FK. Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. Arthritis Rheum. 1999;42(4):790–8.
Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds); Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Food and Nutrition Board; Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press. 2011. http://www.nap.edu/catalog/13050/dietary-reference-intakes-for-calcium-and-vitamin-d Accessed 10 May 2016.
Jetha A, Badley E, Beaton D, Fortin PR, Shiff NJ, Gignac MAM. Unpacking early work experiences of young adults with rheumatic disease: an examination of absenteeism, job disruptions and productivity loss. Arthritis Care Res. 2015;67(9):1246–54.
Jetha A. The impact of arthritis on the early employment experiences of young adults: a literature review. Disabil Health J. 2015;8(3):317–24.
Barth S, Haas J-P, Schlichtiger J, Molz J, Bisdorff B, Michels H, et al. Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS ONE. 2016;11(4):e0153267.
Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KÅ, Nordvåg B-Y, Koldingsnes W, et al. Fertility in women with chronic inflammatory arthritides. Rheumatol Oxf Engl. 2011;50(6):1162–7.
Farr SL, Folger SG, Paulen ME, Curtis KM. Safety of contraceptive methods for women with rheumatoid arthritis: a systematic review. Contraception. 2010;82(1):64–71.
Schikler KN. Is it juvenile rheumatoid arthritis or fibromyalgia? Med Clin N Am. 2000;84(4):967–82.
Anthony KK, Schanberg LE. Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease. Pediatr Clin N Am. 2005;52(2):611–39, vii.
White PH, Ardoin S. Transitioning wisely: improving the connection from pediatric to adult health care. Arthritis Rheumatol. 2016;68(4):789–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
Juvenile Idiopathic Arthritis (JIA) condition fact Sheet | ||
---|---|---|
Definition | JIA is an autoimmune disease defined by arthritis occurring for greater than 6 weeks in a child younger than 16 • Subtypes of JIA include: systemic, oligoarticular, polyarticular (rheumatoid factor positive or negative), enthesitis-related arthritis, psoriatic arthritis, and undifferentiated • Each subtype of JIA has a different presentation | |
Epidemiology | • Prevalence of JIA ranges from 10 to 400 per 100,000 around the world • There is overall a 2:1 female-to-male ratio • Oligoarthritis is the most common subtype of childhood arthritis affecting 50–80 % of all children with chronic arthritis • A substantial number of JIA patients continue to have active arthritis into adulthood | |
Special considerations | Individuals with JIA are at risk for comorbid physical and mental health conditions, including | |
• Persistent arthritis • Growth abnormalities • Ocular complications • Medication toxicity including infection, teratogenic risk | • Anxiety and depression • Macrophage activation syndrome • Chronic pain | |
Individuals are at heightened risk for chronic conditions, including • Uveitis • Atherosclerosis and coronary heart disease • Osteoporosis and fractures • Osteoarthritis • Malignancy • Need for joint replacement surgery • Sjögren’s syndrome | ||
Recommended screening | Patients may require lab screening for medication side effects |
Suggested Reading List
-
Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Cassidy JT (eds). Textbook of pediatric rheumatology, Seventh edition. Philadelphia, PA: Elsevier. 2016
-
Espinosa M, Gottlieb BS. Juvenile Idiopathic Arthritis. Pediatr. Rev. 2012;33, 303–313.
-
Coulson EJ, Hanson HJM, Foster HE. What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatol Oxf Engl. 2014 Dec;53(12):2155–66.
Patient/Caregiver/Provider Resources
-
Arthritis Foundation: http://www.kidsgetarthritistoo.org
-
Getting Accommodations for Juvenile Arthritis at College: https://www.youtube.com/watch?v=ctuj0nXkey0
-
Transition and Secondary School Issues Resources: http://www.gottransition.org
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ronis, T., White, P.H. (2016). Juvenile Idiopathic Arthritis. In: Pilapil, M., DeLaet, D., Kuo, A., Peacock, C., Sharma, N. (eds) Care of Adults with Chronic Childhood Conditions. Springer, Cham. https://doi.org/10.1007/978-3-319-43827-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-43827-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43825-2
Online ISBN: 978-3-319-43827-6
eBook Packages: MedicineMedicine (R0)